24265-21-2

Basic information

• Product Name: 4-Chloro-3,6-dihydro-2H-pyran
• Synonyms: 4-Chloro-3,6-dihydro-2H-pyran
• CAS NO: 24265-21-2
• Molecular Formula: C₅H₇ClO
• Molecular Weight: 118.5615
• Mol File: 24265-21-2.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 160.9°Cat760mmHg
• Flash Point: 59.1°C
• Appearance: /
• Density: 1.14g/cm³
• Vapor Pressure: 3.04mmHg at 25°C
• Refractive Index: 1.48
• CAS DataBase Reference: 4-Chloro-3,6-dihydro-2H-pyran(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Chloro-3,6-dihydro-2H-pyran(24265-21-2)
• EPA Substance Registry System: 4-Chloro-3,6-dihydro-2H-pyran(24265-21-2)

Safety Data

• Hazardous Substances Data: 24265-21-2(Hazardous Substances Data)

Usage

InChI:InChI=1/C5H7ClO/c6-5-1-3-7-4-2-5/h1H,2-4H2

Upstream product

• 188975-30-6 5,6-dihydro-4-trifluoromethylsulfonyloxy-2H-pyran 
• 141534-86-3 (dihydro-2H-pyran-4(3H)-ylidene)hydrazine 
• 1708-29-8 2,5-dihydrofuran 
• 29943-42-8 Tetrahydro-4H-pyran-4-one 

Downstream Products

• 623931-31-7 6,7-dihydro-4H-pyrano[4,3-d][1,3]thiazol-2-amine hydrochloride 

Relevant articles and documents

Nickel-Catalyzed Conversion of Enol Triflates into Alkenyl Halides

A Ni-catalyzed halogenation of enol triflates was developed and it enables the synthesis of a broad range of alkenyl iodides, bromides, and chlorides under mild reaction conditions. The reaction utilizes inexpensive, bench-stable Ni(OAc)2?4 H2O as a precatalyst and proceeds at room temperature in the presence of sub-stoichiometric Zn and either 1,5-cyclooctadiene or 4-(N,N-dimethylamino)pyridine.

A synthetic 4- the position is mixed atom substituted cyclohexenyl halo process of the

The invention relates to a method for synthesizing organic compounds, in particular to a process method for synthesizing 4-site heteroatom-substituted cyclohexenyl halide. The method comprises the following steps of: performing refluxing reaction on 4-sit

HETEROTRICYCLYL 6-ALKYLIDENE-PENEMS AS ΒΕΤΑ-LACTAMASE INHIBITORS

The present invention provides a compound of formula I, pharmaceutical compositions and the use thereof for the treatment of bacterial infection or disease in a patient in need thereof.